The politicization of gender-affirming care for transgender youth has been driven by a narrative that millions of children are using hormones and that this type of care is too freely given. Our findings reveal that is not the case.
The study found that less than 0.1 percent of minors with private insurance are TGD and received puberty blockers or gender-affirming hormone treatment. No TGD patients under age 12 were prescribed gender-affirming hormones.
Collection
[
|
...
]